Clinical characteristics and outcomes of B-ALL with <em>ZNF384</em> rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

Hirabayashi, S; Butler, ER; Ohki, K; Kiyokawa, N; Bergmann, AK; Moricke, A; Boer, JM; Cave, H; Cazzaniga, G; Yeoh, AEJ; Sanada, M; Imamura, T; Inaba, H; Mullighan, C; Loh, ML; Noren-Nystrom, U; Pastorczak, A; Shih, L-Y; Zaliova, M; Pui, C-H; Haas, OA; Harrison, CJ; Moorman, AV; Manabe, A

doi:10.1038/s41375-021-01199-0

Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

Lookup NU author(s): Ellie Butler, Professor Christine Harrison FRCPath FMedSci, Professor Anthony Moorman ORCiD

Downloads

Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Hirabayashi S, Butler ER, Ohki K, Kiyokawa N, Bergmann AK, Moricke A, Boer JM, Cave H, Cazzaniga G, Yeoh AEJ, Sanada M, Imamura T, Inaba H, Mullighan C, Loh ML, Noren-Nystrom U, Pastorczak A, Shih L-Y, Zaliova M, Pui C-H, Haas OA, Harrison CJ, Moorman AV, Manabe A

Publication type: Article

Publication status: Published

Journal: Leukemia

Year: 2021

Volume: 35

Pages: 3272–3277

Print publication date: 01/11/2021

Online publication date: 10/03/2021

Acceptance date: 18/02/2021

Date deposited: 09/04/2021

ISSN (print): 0887-6924

ISSN (electronic): 1476-5551

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41375-021-01199-0

DOI: 10.1038/s41375-021-01199-0

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder reference	Funder name
Czech Health Research Council (NU20-07-00322), Czech,
Blood Cancer, the Grant of the National Center for Child Health and Development, UK,
Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan
Japan Agency for Medical Research and Development (AMED), Japan
National Cancer Institute (CA021765), US,
the Center for Biological Resources (CRB-cancer; BB-0033-00076) of the Robert Debré Hospital, France,
the American Lebanese Syrian Associated Charities (ALSAC), US,
the ERA-NET TRANSCAN EJC granted by Fondation ARC, France,
the Oncode Institute and KiKa Foundation, Netherlands.

ePrints